Yohei Doi, MD, PhD

Fujita Health University, Japan

Disclosure(s): GSK: Advisor/Consultant; Meiji Seika Pharma: Advisor/Consultant; Shionogi: Advisor/Consultant, Honoraria

Poster(s):

• (P-1311) Community-associated carbapenem-resistant gram-negative bacilli infection in Japan
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1387) Distribution and clinical significance of quantitative interferon-gamma release assay among elderly patients with active tuberculosis in Japan.
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1529) Antimicrobial resistance and virulence gene profiles of Klebsiella spp. blood isolates misidentified as Klebsiella pneumoniae
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1565) CRISPR-Cas Systems among Clinical Klebsiella pneumoniae isolates from a Tertiary Hospital in the Philippines and its Potential Association with Antimicrobial Resistance and Hypervirulence
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET